Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Firearms | 22 | 2024 | 631 | 6.140 |
Why?
|
Wounds, Gunshot | 11 | 2024 | 587 | 3.690 |
Why?
|
Drugs, Generic | 6 | 2023 | 455 | 1.230 |
Why?
|
Violence | 5 | 2022 | 936 | 1.180 |
Why?
|
Medicare Part D | 3 | 2023 | 355 | 1.090 |
Why?
|
Blood Donors | 2 | 2017 | 343 | 0.940 |
Why?
|
Cities | 2 | 2024 | 543 | 0.940 |
Why?
|
Research Design | 5 | 2024 | 6209 | 0.920 |
Why?
|
Drug Substitution | 2 | 2021 | 291 | 0.730 |
Why?
|
Physician's Role | 2 | 2017 | 925 | 0.660 |
Why?
|
Drug Costs | 2 | 2018 | 1195 | 0.660 |
Why?
|
Moral Obligations | 1 | 2020 | 91 | 0.660 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2024 | 10397 | 0.640 |
Why?
|
Government Regulation | 2 | 2021 | 525 | 0.630 |
Why?
|
Public Policy | 2 | 2020 | 552 | 0.630 |
Why?
|
Homosexuality, Male | 2 | 2017 | 1344 | 0.620 |
Why?
|
Drug Evaluation | 1 | 2019 | 642 | 0.600 |
Why?
|
Polyarteritis Nodosa | 1 | 2018 | 70 | 0.580 |
Why?
|
Inappropriate Prescribing | 1 | 2020 | 212 | 0.580 |
Why?
|
Polypharmacy | 1 | 2020 | 307 | 0.580 |
Why?
|
State Government | 1 | 2021 | 388 | 0.580 |
Why?
|
Glucagon-Like Peptides | 1 | 2019 | 157 | 0.560 |
Why?
|
Temporal Arteries | 1 | 2018 | 155 | 0.550 |
Why?
|
Facial Injuries | 1 | 2018 | 191 | 0.550 |
Why?
|
Financing, Government | 2 | 2018 | 473 | 0.550 |
Why?
|
Cyclonic Storms | 1 | 2018 | 121 | 0.540 |
Why?
|
Research Support as Topic | 2 | 2024 | 696 | 0.530 |
Why?
|
Health Care Sector | 1 | 2018 | 196 | 0.530 |
Why?
|
Physicians | 4 | 2022 | 4598 | 0.500 |
Why?
|
Prescription Drugs | 2 | 2023 | 635 | 0.490 |
Why?
|
Problem Solving | 1 | 2018 | 443 | 0.490 |
Why?
|
Testis | 1 | 2018 | 783 | 0.480 |
Why?
|
Periodicals as Topic | 2 | 2023 | 1465 | 0.460 |
Why?
|
Therapeutics | 1 | 2014 | 113 | 0.450 |
Why?
|
Internal Medicine | 2 | 2020 | 1064 | 0.450 |
Why?
|
United States | 27 | 2024 | 73039 | 0.430 |
Why?
|
Clinical Competence | 3 | 2024 | 4858 | 0.430 |
Why?
|
Occupational Diseases | 1 | 2020 | 1457 | 0.400 |
Why?
|
Internship and Residency | 4 | 2024 | 5953 | 0.400 |
Why?
|
Disasters | 1 | 2018 | 521 | 0.400 |
Why?
|
Evidence-Based Medicine | 1 | 2024 | 3706 | 0.390 |
Why?
|
Restraint, Physical | 2 | 2023 | 185 | 0.380 |
Why?
|
Drug Approval | 2 | 2021 | 821 | 0.370 |
Why?
|
Suicide, Attempted | 2 | 2021 | 1409 | 0.350 |
Why?
|
Educational Measurement | 1 | 2017 | 1260 | 0.350 |
Why?
|
Health Personnel | 2 | 2022 | 3384 | 0.350 |
Why?
|
Research | 2 | 2021 | 1979 | 0.350 |
Why?
|
Standard of Care | 1 | 2014 | 568 | 0.350 |
Why?
|
Health Expenditures | 3 | 2023 | 2389 | 0.340 |
Why?
|
Health Services Needs and Demand | 1 | 2018 | 1406 | 0.340 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8052 | 0.330 |
Why?
|
Suicide | 1 | 2020 | 1606 | 0.320 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1321 | 0.310 |
Why?
|
Humans | 59 | 2024 | 768171 | 0.300 |
Why?
|
Informed Consent | 1 | 2014 | 1010 | 0.300 |
Why?
|
Patient Selection | 1 | 2020 | 4260 | 0.300 |
Why?
|
Guidelines as Topic | 1 | 2014 | 1397 | 0.300 |
Why?
|
Education, Medical | 1 | 2019 | 1742 | 0.290 |
Why?
|
Biomedical Research | 1 | 2022 | 3463 | 0.260 |
Why?
|
Communication | 1 | 2019 | 3905 | 0.240 |
Why?
|
History, 20th Century | 3 | 2020 | 2766 | 0.240 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2599 | 0.240 |
Why?
|
Safety | 3 | 2024 | 1159 | 0.230 |
Why?
|
Counseling | 2 | 2024 | 1554 | 0.230 |
Why?
|
Holidays | 1 | 2023 | 41 | 0.220 |
Why?
|
Mental Disorders | 1 | 2023 | 6873 | 0.220 |
Why?
|
Accident Prevention | 1 | 2023 | 76 | 0.220 |
Why?
|
Hospitalization | 3 | 2023 | 10840 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
Harm Reduction | 1 | 2023 | 143 | 0.200 |
Why?
|
Fossil Fuels | 1 | 2022 | 53 | 0.200 |
Why?
|
Journal Impact Factor | 1 | 2023 | 157 | 0.190 |
Why?
|
New York | 2 | 2021 | 882 | 0.190 |
Why?
|
Factor Analysis, Statistical | 1 | 2024 | 1001 | 0.190 |
Why?
|
Ownership | 2 | 2023 | 338 | 0.190 |
Why?
|
History, 21st Century | 2 | 2020 | 1573 | 0.190 |
Why?
|
Virus Shedding | 1 | 2022 | 110 | 0.190 |
Why?
|
Risk Assessment | 3 | 2021 | 24318 | 0.180 |
Why?
|
Nursing Staff, Hospital | 1 | 2023 | 350 | 0.170 |
Why?
|
Homicide | 2 | 2021 | 294 | 0.170 |
Why?
|
Pseudobulbar Palsy | 1 | 2019 | 1 | 0.160 |
Why?
|
Colchicine | 1 | 2021 | 257 | 0.160 |
Why?
|
Delirium | 2 | 2021 | 1696 | 0.160 |
Why?
|
Meta-Analysis as Topic | 1 | 2024 | 1363 | 0.160 |
Why?
|
Quinidine | 1 | 2019 | 52 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Dextromethorphan | 1 | 2019 | 37 | 0.160 |
Why?
|
Tourniquets | 1 | 2020 | 111 | 0.160 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.160 |
Why?
|
Financial Management | 1 | 2020 | 161 | 0.160 |
Why?
|
Peer Review, Health Care | 1 | 2019 | 73 | 0.150 |
Why?
|
Off-Label Use | 1 | 2020 | 185 | 0.150 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2020 | 430 | 0.150 |
Why?
|
Drug Industry | 1 | 2024 | 791 | 0.150 |
Why?
|
Child Mortality | 1 | 2020 | 204 | 0.150 |
Why?
|
Advanced Cardiac Life Support | 1 | 2018 | 79 | 0.150 |
Why?
|
Femoral Vein | 1 | 2018 | 155 | 0.150 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 50 | 0.150 |
Why?
|
Puerto Rico | 1 | 2018 | 380 | 0.140 |
Why?
|
Blood Safety | 1 | 2016 | 16 | 0.140 |
Why?
|
Leukocytosis | 1 | 2018 | 251 | 0.140 |
Why?
|
Cluster Analysis | 1 | 2024 | 2732 | 0.140 |
Why?
|
Hematuria | 1 | 2018 | 232 | 0.140 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26379 | 0.140 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 794 | 0.130 |
Why?
|
Epididymis | 1 | 2018 | 227 | 0.130 |
Why?
|
California | 1 | 2020 | 1438 | 0.130 |
Why?
|
Federal Government | 1 | 2018 | 266 | 0.130 |
Why?
|
Parents | 2 | 2023 | 3595 | 0.130 |
Why?
|
Child | 7 | 2023 | 80917 | 0.130 |
Why?
|
Male | 19 | 2024 | 364731 | 0.130 |
Why?
|
Geriatrics | 1 | 2020 | 394 | 0.130 |
Why?
|
Climate Change | 1 | 2022 | 509 | 0.130 |
Why?
|
Cost Savings | 2 | 2019 | 904 | 0.130 |
Why?
|
Alzheimer Disease | 1 | 2017 | 8759 | 0.120 |
Why?
|
United States Food and Drug Administration | 3 | 2021 | 1673 | 0.120 |
Why?
|
United States Office of Research Integrity | 1 | 2014 | 9 | 0.120 |
Why?
|
Civil Rights | 1 | 2016 | 131 | 0.120 |
Why?
|
Therapeutic Equipoise | 1 | 2014 | 29 | 0.120 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 552 | 0.120 |
Why?
|
Mass Casualty Incidents | 1 | 2017 | 180 | 0.120 |
Why?
|
Florida | 1 | 2016 | 417 | 0.120 |
Why?
|
Autopsy | 1 | 2018 | 1011 | 0.120 |
Why?
|
Treatment Failure | 2 | 2020 | 2661 | 0.120 |
Why?
|
Research Personnel | 1 | 2019 | 589 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2021 | 849 | 0.120 |
Why?
|
Connecticut | 1 | 2015 | 366 | 0.120 |
Why?
|
Extremities | 1 | 2020 | 870 | 0.120 |
Why?
|
Commerce | 1 | 2020 | 612 | 0.120 |
Why?
|
Stereotyping | 1 | 2016 | 241 | 0.110 |
Why?
|
Benzodiazepines | 1 | 2020 | 1138 | 0.110 |
Why?
|
Arthralgia | 1 | 2018 | 459 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2024 | 2118 | 0.110 |
Why?
|
Virus Replication | 1 | 2022 | 2458 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2018 | 1836 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5315 | 0.110 |
Why?
|
HIV Infections | 2 | 2017 | 17569 | 0.110 |
Why?
|
Dementia | 2 | 2019 | 2740 | 0.110 |
Why?
|
Incidence | 2 | 2022 | 21538 | 0.110 |
Why?
|
Language | 1 | 2022 | 1557 | 0.100 |
Why?
|
Mothers | 1 | 2023 | 2209 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1515 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1065 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.100 |
Why?
|
Face | 1 | 2018 | 1031 | 0.100 |
Why?
|
Suicidal Ideation | 2 | 2021 | 1462 | 0.100 |
Why?
|
Circadian Rhythm | 1 | 2023 | 2593 | 0.100 |
Why?
|
Pediatrics | 2 | 2024 | 3629 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2566 | 0.090 |
Why?
|
Curriculum | 1 | 2024 | 3782 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8747 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1614 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1514 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1951 | 0.090 |
Why?
|
Biological Products | 1 | 2020 | 947 | 0.090 |
Why?
|
Heart Failure | 1 | 2014 | 11879 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2029 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1381 | 0.080 |
Why?
|
Retinopathy of Prematurity | 1 | 2014 | 449 | 0.080 |
Why?
|
Medicaid | 2 | 2021 | 2840 | 0.080 |
Why?
|
Pulmonary Artery | 1 | 2018 | 1946 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.080 |
Why?
|
Female | 13 | 2024 | 397187 | 0.080 |
Why?
|
Infant, Premature, Diseases | 1 | 2014 | 712 | 0.080 |
Why?
|
Public Health | 2 | 2022 | 2679 | 0.080 |
Why?
|
Adult | 10 | 2024 | 223646 | 0.080 |
Why?
|
Heart Arrest | 1 | 2018 | 1515 | 0.080 |
Why?
|
Air Pollution | 1 | 2022 | 2374 | 0.080 |
Why?
|
Air Pollutants | 1 | 2022 | 2916 | 0.070 |
Why?
|
Hemorrhage | 1 | 2020 | 3466 | 0.070 |
Why?
|
Health Policy | 1 | 2020 | 2697 | 0.070 |
Why?
|
Medicare | 3 | 2021 | 6809 | 0.070 |
Why?
|
Sexual Behavior | 1 | 2017 | 2197 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3858 | 0.070 |
Why?
|
Retrospective Studies | 5 | 2023 | 81760 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3929 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10590 | 0.060 |
Why?
|
Deafness | 1 | 2009 | 460 | 0.060 |
Why?
|
Cochlear Implantation | 1 | 2009 | 317 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4064 | 0.060 |
Why?
|
Infant, Premature | 1 | 2014 | 2123 | 0.060 |
Why?
|
Ultrasonography | 1 | 2018 | 6004 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2019 | 2893 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4850 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3269 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 9092 | 0.050 |
Why?
|
Pain | 1 | 2018 | 5099 | 0.050 |
Why?
|
Oxygen | 1 | 2014 | 4270 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13013 | 0.050 |
Why?
|
Time Factors | 2 | 2022 | 40220 | 0.050 |
Why?
|
Adolescent | 4 | 2023 | 89169 | 0.050 |
Why?
|
Subtilisins | 1 | 2021 | 80 | 0.050 |
Why?
|
Peer Review | 1 | 2023 | 218 | 0.050 |
Why?
|
Environmental Pollution | 1 | 2022 | 125 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41753 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59626 | 0.050 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8616 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2022 | 421 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11101 | 0.040 |
Why?
|
Nevada | 1 | 2017 | 20 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54924 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1643 | 0.030 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2019 | 451 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 65379 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15662 | 0.030 |
Why?
|
Aged | 4 | 2021 | 171502 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20762 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2021 | 1474 | 0.030 |
Why?
|
Middle Aged | 5 | 2022 | 223487 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2014 | 26421 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2009 | 3415 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2021 | 4887 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1365 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2089 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2420 | 0.030 |
Why?
|
Health Surveys | 1 | 2022 | 4057 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 74944 | 0.020 |
Why?
|
Politics | 1 | 2017 | 822 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3479 | 0.020 |
Why?
|
Audiology | 1 | 2009 | 23 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3886 | 0.020 |
Why?
|
Length of Stay | 1 | 2023 | 6498 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2785 | 0.020 |
Why?
|
Language Development Disorders | 1 | 2009 | 194 | 0.020 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1475 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13290 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.020 |
Why?
|
Education | 1 | 2009 | 533 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12466 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5107 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3620 | 0.020 |
Why?
|
Neoplasms | 1 | 2014 | 22371 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14729 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5458 | 0.020 |
Why?
|
Self Efficacy | 1 | 2009 | 643 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3250 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13668 | 0.010 |
Why?
|
Child, Preschool | 2 | 2019 | 42669 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7951 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3326 | 0.010 |
Why?
|
Patient Compliance | 1 | 2009 | 2697 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36535 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2009 | 7852 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 60066 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2009 | 5520 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39354 | 0.000 |
Why?
|
Concepts
(249)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(93)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_